A&R
|
Alteration and Renovation
|
ACF
|
Administration for Children
and Families
|
ACH
|
Automated Clearinghouse
|
AHRQ
|
Agency for Healthcare Research
and Quality
|
AIA
|
American Institute of
Architects
|
AoA
|
Administration on Aging
|
AOO
|
Authorized Organizational
Official
|
APAC
|
Annual Payback Activities
Certification
|
AREA
|
Academic Research and
Enhancement Award
|
ASHRAE
|
American Society of Heating,
Refrigeration and Air Conditioning
Engineers
|
CDC
|
Centers for Disease Control
and Prevention
|
CFR
|
Code of Federal Regulations
|
CGMO
|
Chief Grants Management
Officer
|
CMS
|
Centers for Medicare and
Medicaid Services
|
CoC
|
Certificate of Confidentiality
|
COR
|
Career Opportunities in
Research Education and Training Program
|
CRISP
|
Computer Retrieval of
Information on Scientific Projects
|
CSR
|
Center for Scientific Review
|
DAB
|
Departmental Appeals Board
|
DCA
|
Division of Cost Allocation,
HHS
|
DEA
|
Drug Enforcement
Administration
|
DEOIR
|
Division of Extramural
Outreach and Information Resources, NIH
|
DES
|
Department of Engineering
Services, NIH
|
DFAS
|
Division of Financial Advisory
Services, NIH
|
DoC
|
Department of Commerce
|
DoD
|
Department of Defense
|
DoL
|
Department of Labor
|
DPM
|
Division of Payment
Management, HHS
|
DSMB
|
Data and Safety Monitoring
Board
|
EA
|
Expanded Authorities
|
EO
|
Executive Order
|
eRA
|
Electronic Research
Administration
|
F&A
|
Facilities and Administrative
(costs)
|
FAC
|
Federal Audit Clearinghouse
|
FAR
|
Federal Acquisition Regulation
|
FCTR
|
Federal Cash Transactions
Report (SF 272)
|
FDA
|
Food and Drug Administration
|
FDP
|
Federal Demonstration
Partnership
|
FEMA
|
Federal Emergency Management
Agency
|
FIC
|
Fogarty International Center
|
FICA
|
Federal Insurance
Contributions Act
|
FOI
|
Freedom of Information
|
FOIA
|
Freedom of Information Act
|
FSR
|
Financial Status Report (SF
269 or 269A)
|
FTR
|
Federal Travel Regulation
|
FWA
|
Federal-Wide Assurance
|
GCRC
|
General Clinical Research
Centers
|
GMO
|
Grants Management Officer
|
GMS
|
Grants Management Specialist
|
GMP
|
Guaranteed Maximum Price
|
GPO
|
Government Printing Office
|
GSA
|
General Services
Administration
|
hESC
|
Human Embryonic Stem Cells
|
HHS
|
Department of Health and Human
Services
|
HRSA
|
Health Resources and Services
Administration
|
HVAC
|
Heating, Ventilating, and Air
Conditioning
|
IACUC
|
Institutional Animal Care and
Use Committee
|
IBC
|
Institutional Biosafety
Committee
|
IC
|
Institute or Center
|
IDE
|
Investigational Device
Exception
|
IHS
|
Indian Health Service
|
IND
|
Investigational New Drug
|
IPA
|
Intergovernmental Personnel
Act
|
IR&D
|
Independent Research and
Development
|
IRB
|
Institutional Review Board
|
IRG
|
Initial Review Group
|
IRS
|
Internal Revenue Service
|
K award
|
Career award
|
Kirschstein-NRSA
|
Ruth L. Kirschstein National
Research Service Award
|
LWOP
|
Leave Without Pay
|
MARC-U*STAR
|
Minority Access to Research
Careers Undergraduate Student Training in Academic Research Program
|
MOU
|
Memorandum Of Understanding
|
MPA
|
Multiple Project Assurance
|
NCRR
|
National Center for Research
Resources
|
NEARC
|
National External Audit Review Center, OIG
|
NEI
|
National Eye Institute
|
NEPA
|
National Environmental Policy
Act
|
NFI
|
Notice of Federal Interest
|
NFPA
|
National Fire Protection
Association
|
NGA
|
Notice of Grant Award
|
NHSC
|
National Health Service Corps
|
NICHD
|
National Institute for Child
Health and Human Development
|
NIDCR
|
National Institute of Dental
and Craniofacial Research
|
NIGMS
|
National Institute of General Medical Sciences
|
NIH
|
National Institutes of Health
|
NIHGPS
|
National Institutes of Health
Grants Policy Statement
|
NIMH
|
National Institute of Mental
Health
|
NINR
|
National Institute on Nursing
Research
|
NLM
|
National Library of Medicine
|
NRFA
|
Notice of Research Fellowship
Award
|
NTIS
|
National Technical Information
Service
|
OBA
|
Office of Biotechnology
Activities, NIH
|
OCR
|
Office for Civil Rights, HHS
|
OER
|
Office of Extramural Research,
NIH
|
OFCCP
|
Office of Federal Contract
Compliance Programs, DoL
|
OFM
|
Office of Financial
Management, NIH
|
OHRP
|
Office for Human Research
Protections, HHS
|
OIG
|
Office of the Inspector
General
|
OLAW
|
Office of Laboratory Animal
Welfare, NIH
|
OMB
|
Office of Management and
Budget
|
ONR
|
Office of Naval Research
|
OPERA
|
Office of Policy for
Extramural Research Administration, NIH
|
OPHS
|
Office of Public Health and
Science
|
ORI
|
Office of Research Integrity,
HHS
|
PA
|
Program Announcement
|
PD
|
Program Director/Project
Director
|
PHS
|
Public Health Service
|
PI
|
Principal Investigator
|
P.L.
|
Public Law
|
PMS
|
Payment Management System, HHS
|
PO
|
Program Official
|
PSC
|
Payback Service Center, NIH
|
R&D
|
Research and Development
|
RFA
|
Request For Applications
|
RFP
|
Request For Proposals
|
S&W
|
Salaries and Wages
|
SAMHSA
|
Substance Abuse and Mental
Health Services Administration
|
SBA
|
Small Business Administration
|
SBC
|
Small Business Concern
|
SBIR
|
Small Business Innovation
Research Program
|
SEP
|
Special Emphasis Panel
|
SF
|
Standard Form
|
SII
|
Successor-In-Interest
|
SNAP
|
Streamlined Non-competing
Award Process
|
SO
|
Signing Official
|
SPOC
|
State Single Point of Contact
|
SRA
|
Scientific Review
Administrator
|
SRG
|
Scientific Review Group
|
STTR
|
Small Business Technology
Transfer Program
|
U.S.C.
|
United States Code
|
USDA
|
United States Department of
Agriculture
|
USPS
|
United States Postal Service
|
VA
|
Department of Veterans Affairs
|
VAMC
|
VA Medical Center
|
VANPC
|
VA-Affiliated Non-Profit
research Corporation
|
alteration and renovation
|
Work
that changes the interior arrangements or other physical characteristics of
an existing facility or of installed equipment so that it can be used more
effectively for its currently designated purpose or adapted to an alternative
use to meet a programmatic requirement. Major A&R (including modernization,
remodeling, or improvement) of an existing building is permitted under an NIH
grant only when the authorizing statute for the program specifically allows
that activity. (See “Allowability of Costs/Activities—Selected
Items of Cost—Alteration and Renovation” and “Allowability
of Costs/Activities—Selected Items of Cost—Construction.”)
|
application
|
A request for financial support of a project or activity
submitted to NIH on specified forms and in accordance with NIH instructions.
(See “Application and Review Processes”
for detailed information about the application process, including an
explanation of the types of applications.)
|
approved budget
|
The financial expenditure plan for the grant-supported
project or activity, including revisions approved by NIH and permissible
revisions made by the grantee. The approved budget consists of Federal
(grant) funds and, if required by the terms and conditions of the award,
non-Federal participation in the form of matching or cost sharing. The
approved budget specified in the NGA may be shown in detailed budget
categories or as total costs without a categorical breakout. Expenditures charged
to an approved budget that consists of both Federal and non-Federal shares
are deemed to be borne by the grantee in the same proportion as the
percentage of Federal/non-Federal participation in the overall budget.
|
authorized
organizational official
|
The individual, named by the applicant organization, who
is authorized to act for the applicant and to assume the obligations imposed
by the Federal laws, regulations, requirements, and conditions that apply to
grant applications or grant awards. This official is equivalent to the SO in
NIH’s eRA Commons.
|
award
|
The provision of funds by NIH, based on an approved
application and budget or progress report, to an organizational entity or an
individual to carry out a project or activity.
|
awarding office
|
The NIH IC responsible for the award, administration, and
monitoring of particular grants.
|
budget period
|
The intervals of time (usually 12 months each) into which
a project period is divided for budgetary and funding purposes.
|
capital
expenditure
|
The cost of an asset (land, building, equipment),
including the cost to put it in place. A capital expenditure for equipment
includes the net invoice price and the cost of any modifications,
attachments, accessories, or auxiliary apparatus to make it usable for the purpose
for which it was acquired. Other charges, such as taxes, in-transit
insurance, freight, and installation, may be included in capital expenditure
costs in accordance with the recipient’s regular accounting practices
consistently applied regardless of the source of funds. (See “Administrative Requirements—Changes in Project
and Budget
—Prior-Approval Requirements—Capital Expenditures.”)
|
clinical research
|
Patient-oriented research, including epidemiologic and behavioral
studies, outcomes research, and health services research. Patient-oriented
research is research conducted with human subjects (or on material of human
origin such as tissues, specimens, and cognitive phenomena) in which a
researcher directly interacts with human subjects. It includes research on
mechanisms of human disease, therapeutic interventions, clinical trials, and
development of new technologies, but does not include in vitro studies that
use human tissues that cannot be linked to a living individual. Studies
falling under 45 CFR 46.101(a) (4) are not considered clinical research
for purposes of this definition.
|
clinical trial
|
A biomedical or behavioral research study of human
subjects that is designed to answer specific questions about biomedical or
behavioral interventions (drugs, treatments, devices, or new ways of using
known drugs, treatments, or devices). Clinical trials are used to determine
whether new biomedical or behavioral interventions are safe, efficacious, and
effective. Clinical trials of an experimental drug, treatment, device, or
intervention may proceed through four phases:
Phase I. Testing in a small group of people (e.g. 20-80)
to determine efficacy and evaluate safety (e.g., determine a safe dosage
range and identify side effects).
Phase II. Study in a larger group of people (several
hundred) to determine efficacy and further evaluate safety.
Phase III. Study to determine efficacy in large groups of
people (from several hundred to several thousand) by comparing the intervention
to other standard or experimental interventions, to monitor adverse effects,
and to collect information to allow safe use.
Phase IV. Studies done after the intervention has been
marketed. These studies are designed to monitor the effectiveness of the
approved intervention in the general population and to collect information
about any adverse effects associated with widespread use.
|
competitive
segment
|
The initial project period recommended for support (up to
5 years) or each extension of a project period resulting from a competing
continuation award.
|
consortium agreement
|
A formalized agreement whereby a research project is
carried out by the grantee and one or more other organizations that are
separate legal entities. Under the agreement, the grantee must perform a
substantive role in the conduct of the planned research and not merely serve
as a conduit of funds to another party or parties. (See “Consortium Agreements” in Part II, Subpart
B.)
|
contract under a grant
|
A written agreement between a grantee and a third party to
acquire routine goods or services.
|
consultant
|
An individual who provides professional advice or services
for a fee, but normally not as an employee of the engaging party. In unusual
situations, an individual may be both a consultant and an employee of the
same party, receiving compensation for some services as a consultant and for
other work as a salaried employee. Consultants also include firms that
provide professional advice or services. (See “Allowability
of Costs/Activities—Selected Items of Cost—Consultant Services.”)
|
cooperative agreement
|
A support mechanism used when there will be substantial
Federal scientific or programmatic involvement. Substantial involvement means
that, after award, scientific or program staff will assist, guide,
coordinate, or participate in project activities.
|
co-investigator
|
An individual involved with the PI in the scientific
development or execution of a project. The co-investigator (collaborator) may
be employed by, or be affiliated with, the applicant/grantee organization or
another organization participating in the project under a consortium
agreement. A co-investigator typically devotes a specified percentage of time
to the project and is considered “key personnel.” The designation of a
co-investigator, if applicable, does not affect the PI’s roles and
responsibilities as specified in the NIHGPS.
|
cost overrun
|
Any amount charged in excess of the Federal share of costs
for the project period (competitive segment).
|
cost sharing
|
See “matching or cost
sharing” in this section.
|
direct costs
|
Costs that can be specifically identified with a
particular project or activity.
|
domestic
organization
|
A public (including a State or other governmental agency)
or private non-profit or for-profit organization that is located in the United States or its territories, is subject to U.S. laws, and assumes legal and financial
accountability for awarded funds and for the performance of the
grant-supported activities.
|
equipment
|
An article of tangible nonexpendable personal property
that has a useful life of more than 1 year and an acquisition cost per unit
that equals or exceeds $5,000 or the capitalization threshold established by
the organization, whichever is less.
|
expanded
authorities
|
Operating authorities provided to grantees that waive the
requirement for NIH prior approval for specified actions (see “Administrative Requirements—Changes in Project
and Budget—Expanded Authorities”).
|
facilities
and administrative costs
|
Costs that are incurred by a grantee for common or joint
objectives and cannot be identified specifically with a particular project or
program. These costs also are known as “indirect costs.”
|
Federal Demonstration Partnership
|
A cooperative initiative among some Federal agencies,
including NIH, selected organizations receiving Federal funding for research,
and certain professional associations. Its efforts include demonstration
projects intended to simplify and standardize Federal requirements in order
to increase research productivity and reduce administrative costs.
|
Federal
institution
|
A Cabinet-level department or independent agency of the
executive branch of the Federal government or any component organization of
such a department or agency.
|
fee
|
An amount, in addition to actual, allowable costs, paid to
an organization providing goods or services consistent with normal commercial
practice. This payment also is referred to as “profit.” (See “Grants to For-Profit Organizations—Small Business
Innovation Research and Small Business Technology Transfer Programs—Allowable
Costs and Fee—Profit or Fee.”)
|
financial
assistance
|
Transfer by NIH of money or property to an eligible entity
to support or stimulate a public purpose authorized by statute.
|
foreign
component
|
The performance of any significant scientific element or
segment of a project outside of the United States, either by the grantee or
by a researcher employed by a foreign organization, whether or not grant
funds are expended. Activities that would meet this definition include, but
are not limited to, (1) the involvement of human subjects or animals, (2)
extensive foreign travel by grantee project staff for the purpose of data
collection, surveying, sampling, and similar activities, or (3) any activity
of the grantee that may have an impact on U.S. foreign policy through
involvement in the affairs or environment of a foreign country. Foreign
travel for consultation is not considered a foreign component. (See “Grants to Foreign Institutions, International
Organizations, and Domestic Grants with Foreign Components.”)
|
foreign
institution
|
An organization located in a country other than the United States and its territories that is subject to the laws of that country, regardless
of the citizenship of the proposed PI.
|
for-profit
organization
|
An organization, institution, corporation, or other legal
entity that is organized or operated for the profit or financial benefit of
its shareholders or other owners. Such organizations also are referred to as
“commercial organizations.”
|
full-time
appointment
|
The number of days per week and/or months per year
representing full-time effort at the applicant/grantee organization, as
specified in organizational policy. The organization’s policy must be applied
consistently regardless of the source of support.
|
grant
|
A financial assistance mechanism providing money,
property, or both to an eligible entity to carry out an approved project or
activity. A grant is used whenever the NIH IC anticipates no substantial
programmatic involvement with the recipient during performance of the
financially assisted activities.
|
grant-supported project or
activity
|
Those activities specified or described in a grant
application or in a subsequent submission that are approved by an NIH IC for
funding, regardless of whether Federal funding constitutes all or only a
portion of the financial support necessary to carry them out.
|
grantee
|
The organization or individual awarded a grant or
cooperative agreement by NIH that is responsible and accountable for the use
of the funds provided and for the performance of the grant-supported project
or activity. The grantee is the entire legal entity even if a particular
component is designated in NGA. The grantee is legally responsible and
accountable to NIH for the performance and financial aspects of the
grant-supported project or activity.
|
Grants
Management
Officer
|
An NIH official responsible for the business management
aspects of grants and cooperative agreements, including review, negotiation,
award, and administration, and for the interpretation of grants
administration policies and provisions. Only GMOs are authorized to obligate
NIH to the expenditure of funds and permit changes to approved projects on
behalf of NIH. Each NIH IC that awards grants has one or more GMOs with
responsibility for particular programs or awards.
|
Grants
Management Specialist
|
An NIH staff member who oversees the business and other
non-programmatic aspects of one or more grants and/or cooperative agreements.
These activities include, but are not limited to, evaluating grant
applications for administrative content and compliance with statutes,
regulations, and guidelines; negotiating grants; providing consultation and
technical assistance to grantees; and administering grants after award.
|
hospital
|
A non-profit or for-profit hospital or a medical care
provider component of a non-profit organization (for example, a foundation).
The term includes all types of medical, psychiatric, and dental facilities,
such as clinics, infirmaries, and sanatoria.
|
human subject
|
A living individual about whom an investigator (whether
professional or student) conducting research obtains data through
intervention or interaction with the individual or obtains identifiable
private information. Regulations governing the use of human subjects in research
extend to use of human organs, tissues, and body fluids from identifiable
individuals as human subjects and to graphic, written, or recorded
information derived from such individuals. (See “Requirements
Affecting the Rights and Welfare of Individuals as Research Subjects,
Patients, or Recipients of Services—Human Subjects.”)
|
indirect costs
|
See “facilities
and administrative costs.”
|
Institute or
Center
|
The NIH organizational component responsible for a
particular grant program or set of activities. The terms “NIH IC” or
“awarding office” are used throughout this document to designate a point of
contact for advice and interpretation of grant requirements and to establish
the focal point for requesting necessary prior approvals or changes in the
terms and conditions of award. In the latter case, the terms refer
specifically to the designated GMO.
|
institutional base salary
|
The annual compensation paid by an organization for an
employee’s appointment, whether that individual’s time is spent on research,
teaching, patient care, or other activities. Base salary excludes any income
that an individual is permitted to earn outside of duties for the
applicant/grantee organization. Base salary may not be increased as a result
of replacing organizational salary funds with NIH grant funds. (See “Allowability of Costs/Activities—Selected Items of
Cost—Salaries and Wages.”)
|
international
organization
|
An organization that identifies itself as international or
intergovernmental and has membership from, and represents the interests of,
more than one country, without regard to whether the headquarters of the
organization and location of the activity are inside or outside of the United
States.
|
key personnel
|
The PI and other individuals who contribute to the
scientific development or execution of a project in a substantive, measurable
way, whether or not they receive salaries or compensation under the grant.
Typically these individuals have doctoral or other professional degrees,
although individuals at the masters or baccalaureate level may be considered
key personnel if their involvement meets this definition. Consultants also
may be considered key personnel if they meet this definition. “Zero percent”
effort or “as needed” is not an acceptable level of involvement for key
personnel.
|
matching or cost
sharing
|
The value of third-party in-kind contributions and the
portion of the costs of a federally assisted project or program not borne by
the Federal government. Matching or cost sharing may be required by law,
regulation, or administrative decision of an NIH IC. Costs used to satisfy
matching or cost-sharing requirements are subject to the same policies
governing allowability as other costs under the approved budget.
|
modular
application
|
A type of grant application in which support is requested
in specified increments without the need for detailed supporting information
related to separate budget categories. When modular procedures apply, they
affect not only application preparation but also review of the application,
award, and post-award administration.
|
monitoring
|
A process whereby the programmatic and business management
performance aspects of a grant are assessed by reviewing information gathered
from various required reports, audits, site visits, and other sources.
|
new investigator
|
An individual who has not previously served as a PI on any
PHS-supported research project other than a small grant (R03), an Academic
Research Enhancement Award (R15), an exploratory development grant (R21), or
certain research career awards directed principally to physicians, dentists,
or veterinarians at the beginning of their research careers ((K01, K08, and
K12). Current or past recipients of Independent Scientist and other
non-mentored career awards (K02 and K04) are not considered “new
investigators.”
|
Notice of Grant Award
|
The legally binding document that notifies the grantee and
others that an award has been made, contains or references all terms and
conditions of the award, and documents the obligation of Federal funds. The
award notice may be in letter format and may be issued electronically.
|
organization
|
A generic term used to refer to an educational institution
or other entity, including an individual, which applies for or receives an
NIH grant or cooperative agreement.
|
other support
|
Includes all financial resources, whether Federal,
non-Federal, commercial or organizational, available in direct support of an
individual’s research endeavors, including, but not limited to, research
grants, cooperative agreements, contracts, or organizational awards. Other
support does not include training awards, prizes, or gifts.
|
Phase III clinical trial
|
As defined by NIH, a broadly based prospective Phase III
clinical investigation (usually involving several hundred or more human
subjects) to evaluate an experimental intervention in comparison with a
standard or control intervention or to compare two or more existing
treatments. The definition includes pharmacologic, non-pharmacologic, and
behavioral interventions given for disease prevention, prophylaxis,
diagnosis, or therapy. Community trials and other population-based
intervention trials also are included. (See “clinical
trial.”)
|
Principal Investigator/
Program Director/Project Director
|
An individual designated by the grantee to direct the
project or activity being supported by the grant. He or she is responsible
and accountable to the grantee and NIH for the proper conduct of the project
or activity.
|
prior approval
|
Written approval from the designated GMO required for
specified post-award changes in the approved project or budget. Such approval
must be obtained before undertaking the proposed activity or spending NIH
funds (see “Administrative
Requirements—Changes in Project and Budget—Prior-Approval Requirements”).
|
priority score
|
A numerical rating of an application that reflects the
scientific merit of the proposed research relative to stated evaluation
criteria.
|
profit
|
See “fee.”
|
program
|
A coherent assembly of plans, project activities, and
supporting resources contained within an administrative framework, the
purpose of which is to implement an organization’s mission or some specific
program-related aspect of that mission. For the NIHGPS, “program” refers to
those NIH programs that carry out their missions through the award of grants
or cooperative agreements to other organizations.
|
program income
|
Gross income earned by a grantee that is directly
generated by the grant-supported project or activity or earned as a result of
the award (see “Administrative Requirements—Management
Systems and Procedures—Program Income”).
|
Program Official
|
The NIH official responsible for the programmatic,
scientific, and/or technical aspects of a grant.
|
progress report
|
Periodic, usually annual, report submitted by the grantee
and used by NIH to assess progress and, except for the final progress report
of a project period, to determine whether to provide funding for the budget
period subsequent to that covered by the report.
|
project period
|
The total time for which support of a project has been
programmatically approved. The total project period comprises the initial
competitive segment, any subsequent competitive segments resulting from a
competing continuation award, and non-competing extensions.
|
real property
|
Land, including land improvements, structures, and
appurtenances, but not movable machinery and equipment.
|
recipient
|
The organizational entity or individual receiving a grant
or cooperative agreement. See “grantee.”
|
research
|
A systematic, intensive study intended to increase
knowledge or understanding of the subject studied, a systematic study
specifically directed toward applying new knowledge to meet a recognized
need, or a systematic application of knowledge to the production of useful
materials, devices, and systems or methods, including design, development,
and improvement of prototypes and new processes to meet specific
requirements. Also termed “research and development.”
|
research
misconduct
|
Fabrication, falsification, or plagiarism in proposing,
performing, or reporting research, or in reporting research results.
Fabrication is making up data or results and recording or reporting them.
Falsification is manipulating research materials, equipment, or processes, or
changing or omitting data or results such that research is not accurately
represented in the research record. Plagiarism is the appropriation of
another person’s ideas, processes, results, or words without giving
appropriate credit. The term does not include honest error or honest differences
of opinion.
|
significant
rebudgeting
|
A threshold that is reached when expenditures in a single
direct cost budget category deviate (increase or decrease) from the
categorical commitment level established for the budget period by more than
25 percent of the total costs awarded. Significant rebudgeting is one
indicator of change in scope.
|
small business concern
|
A business that is independently owned and operated and
not dominant in its field of operation; has its principal place of business
in the United States and is organized for profit; is at least 51 percent
owned, or in the case of a publicly owned business, at least 51 percent of
its voting stock is owned by U.S. citizens or lawfully admitted permanent
resident aliens; has, including its affiliates, not more than 500 employees;
and meets other regulatory requirements established by the SBA at 13 CFR
121.
|
State government
|
The government of any State of the United States, the
District of Columbia, the Commonwealth of Puerto Rico, any U.S. territory or
possession, or any agency or instrumentality of a State exclusive of local
governments. For purposes of NIH grants, federally recognized Indian tribal
governments generally are considered State governments. State institutions of
higher education and State hospitals are not considered State governments for
HHS’s general administrative requirements for grants and the NIHGPS.
|
stipend
|
A payment made to an individual under a fellowship or
training grant in accordance with preestablished levels to provide for the
individual’s living expenses during the period of training. A stipend is not
considered compensation for the services expected of an employee.
|
suspension
|
Temporary withdrawal of a grantee’s authority to obligate
grant funds, pending either corrective action by the grantee, as specified by
NIH, or a decision by NIH to terminate the award. This meaning of the term
“suspension” differs from that used in conjunction with the debarment and
suspension process (see “Public Policy
Requirements and Objectives—Ethical and Safe Conduct in Science and
Organizational Operations—Debarment and Suspension” and “Administrative Requirements—Enforcement Actions.”)
|
termination
|
Permanent withdrawal by NIH of a grantee’s authority to
obligate previously awarded grant funds before that authority would otherwise
expire, including the voluntary relinquishment of that authority by the
grantee.
|
terms and
conditions of award
|
All legal requirements imposed on a grant by NIH, whether
based on statute, regulation, policy, or other document referenced in the
grant award, or specified by the grant award document itself. The NGA may
include both standard and special conditions that are considered necessary to
attain the grant’s objectives, facilitate post-award administration of the
grant, conserve grant funds, or otherwise protect the Federal government’s
interests.
|
total project costs
|
The total allowable costs (both direct costs and F&A
costs) incurred by the grantee to carry out a grant-supported project or
activity. Total project costs include costs charged to the NIH grant and
costs borne by the grantee to satisfy a matching or cost-sharing requirement.
|
United States
|
The 50 States, territories, and possessions of the United
States, the Commonwealth of Puerto Rico, the Trust Territory of the Pacific
Islands, and the District of Columbia.
|
withholding of support
|
A decision by NIH not to make a non-competing continuation
award within the current competitive segment.
|